ArticleEClinicalMedicine2026

Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trial.

Robert Sutton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.